Maxwell Mulcahy

Maxwell Mulcahy is a seasoned professional with extensive experience in patient advocacy and engagement across the pharmaceutical and non-profit sectors. Currently serving as the Director of U.S. Patient Advocacy at Apellis Pharmaceuticals, Maxwell develops patient engagement strategies for complement-driven diseases and collaborates with advocacy groups to enhance patient-focused drug development. Previously, roles included Director of Patient Advocacy at MorphoSys, Associate Director of Patient Engagement at Alkermes, and Senior Director of Strategic Initiatives at Cancer Support Community, showcasing a strong emphasis on patient needs in clinical research and emotional support. Earlier experience includes leadership positions at the Lymphoma Research Foundation and the Jewish Council for Public Affairs, highlighting expertise in education programs, policy advocacy, and strategic partnership development. Maxwell holds degrees from Syracuse University and Baruch College.